Global Nervous System Medications Supply, Demand and Key Producers, 2023-2029
The global Nervous System Medications market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Nervous System Medications production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nervous System Medications, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nervous System Medications that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nervous System Medications total production and demand, 2018-2029, (K Units)
Global Nervous System Medications total production value, 2018-2029, (USD Million)
Global Nervous System Medications production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Nervous System Medications consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Nervous System Medications domestic production, consumption, key domestic manufacturers and share
Global Nervous System Medications production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Nervous System Medications production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Nervous System Medications production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Nervous System Medications market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Teva, Novartis, AstraZeneca, Takeda, Johnson & Johnson, EliLilly, Otsuka and Merck, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nervous System Medications market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Nervous System Medications Market, By Region:
1. How big is the global Nervous System Medications market?
2. What is the demand of the global Nervous System Medications market?
3. What is the year over year growth of the global Nervous System Medications market?
4. What is the production and production value of the global Nervous System Medications market?
5. Who are the key producers in the global Nervous System Medications market?
6. What are the growth factors driving the market demand?
This report studies the global Nervous System Medications production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nervous System Medications, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nervous System Medications that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nervous System Medications total production and demand, 2018-2029, (K Units)
Global Nervous System Medications total production value, 2018-2029, (USD Million)
Global Nervous System Medications production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Nervous System Medications consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Nervous System Medications domestic production, consumption, key domestic manufacturers and share
Global Nervous System Medications production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Nervous System Medications production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Nervous System Medications production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Nervous System Medications market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Teva, Novartis, AstraZeneca, Takeda, Johnson & Johnson, EliLilly, Otsuka and Merck, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nervous System Medications market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Nervous System Medications Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Anesthetic
- Painkiller
- Psychostimulants
- Antiepileptic Drugs
- Anti-Parkinson Drugs
- Others
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Pfizer
- Teva
- Novartis
- AstraZeneca
- Takeda
- Johnson & Johnson
- EliLilly
- Otsuka
- Merck
- Yangtze River Pharmaceutical
- Humanwell Healthcare
- CSPC-NBP Pharmaceutical
- Nhwa Pharmaceutical
- Qilu Pharma
1. How big is the global Nervous System Medications market?
2. What is the demand of the global Nervous System Medications market?
3. What is the year over year growth of the global Nervous System Medications market?
4. What is the production and production value of the global Nervous System Medications market?
5. Who are the key producers in the global Nervous System Medications market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Nervous System Medications Introduction
1.2 World Nervous System Medications Supply & Forecast
1.2.1 World Nervous System Medications Production Value (2018 & 2022 & 2029)
1.2.2 World Nervous System Medications Production (2018-2029)
1.2.3 World Nervous System Medications Pricing Trends (2018-2029)
1.3 World Nervous System Medications Production by Region (Based on Production Site)
1.3.1 World Nervous System Medications Production Value by Region (2018-2029)
1.3.2 World Nervous System Medications Production by Region (2018-2029)
1.3.3 World Nervous System Medications Average Price by Region (2018-2029)
1.3.4 North America Nervous System Medications Production (2018-2029)
1.3.5 Europe Nervous System Medications Production (2018-2029)
1.3.6 China Nervous System Medications Production (2018-2029)
1.3.7 Japan Nervous System Medications Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nervous System Medications Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Nervous System Medications Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Nervous System Medications Demand (2018-2029)
2.2 World Nervous System Medications Consumption by Region
2.2.1 World Nervous System Medications Consumption by Region (2018-2023)
2.2.2 World Nervous System Medications Consumption Forecast by Region (2024-2029)
2.3 United States Nervous System Medications Consumption (2018-2029)
2.4 China Nervous System Medications Consumption (2018-2029)
2.5 Europe Nervous System Medications Consumption (2018-2029)
2.6 Japan Nervous System Medications Consumption (2018-2029)
2.7 South Korea Nervous System Medications Consumption (2018-2029)
2.8 ASEAN Nervous System Medications Consumption (2018-2029)
2.9 India Nervous System Medications Consumption (2018-2029)
3 WORLD NERVOUS SYSTEM MEDICATIONS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Nervous System Medications Production Value by Manufacturer (2018-2023)
3.2 World Nervous System Medications Production by Manufacturer (2018-2023)
3.3 World Nervous System Medications Average Price by Manufacturer (2018-2023)
3.4 Nervous System Medications Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Nervous System Medications Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Nervous System Medications in 2022
3.5.3 Global Concentration Ratios (CR8) for Nervous System Medications in 2022
3.6 Nervous System Medications Market: Overall Company Footprint Analysis
3.6.1 Nervous System Medications Market: Region Footprint
3.6.2 Nervous System Medications Market: Company Product Type Footprint
3.6.3 Nervous System Medications Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Nervous System Medications Production Value Comparison
4.1.1 United States VS China: Nervous System Medications Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Nervous System Medications Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Nervous System Medications Production Comparison
4.2.1 United States VS China: Nervous System Medications Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Nervous System Medications Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Nervous System Medications Consumption Comparison
4.3.1 United States VS China: Nervous System Medications Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Nervous System Medications Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Nervous System Medications Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Nervous System Medications Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Nervous System Medications Production Value (2018-2023)
4.4.3 United States Based Manufacturers Nervous System Medications Production (2018-2023)
4.5 China Based Nervous System Medications Manufacturers and Market Share
4.5.1 China Based Nervous System Medications Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Nervous System Medications Production Value (2018-2023)
4.5.3 China Based Manufacturers Nervous System Medications Production (2018-2023)
4.6 Rest of World Based Nervous System Medications Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Nervous System Medications Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Nervous System Medications Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Nervous System Medications Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Nervous System Medications Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Anesthetic
5.2.2 Painkiller
5.2.3 Psychostimulants
5.2.4 Antiepileptic Drugs
5.2.5 Anti-Parkinson Drugs
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Nervous System Medications Production by Type (2018-2029)
5.3.2 World Nervous System Medications Production Value by Type (2018-2029)
5.3.3 World Nervous System Medications Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Nervous System Medications Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacy
6.2.2 Retail Pharmacy
6.2.3 Online Pharmacy
6.3 Market Segment by Application
6.3.1 World Nervous System Medications Production by Application (2018-2029)
6.3.2 World Nervous System Medications Production Value by Application (2018-2029)
6.3.3 World Nervous System Medications Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Nervous System Medications Product and Services
7.1.4 Pfizer Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Teva
7.2.1 Teva Details
7.2.2 Teva Major Business
7.2.3 Teva Nervous System Medications Product and Services
7.2.4 Teva Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Teva Recent Developments/Updates
7.2.6 Teva Competitive Strengths & Weaknesses
7.3 Novartis
7.3.1 Novartis Details
7.3.2 Novartis Major Business
7.3.3 Novartis Nervous System Medications Product and Services
7.3.4 Novartis Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Novartis Recent Developments/Updates
7.3.6 Novartis Competitive Strengths & Weaknesses
7.4 AstraZeneca
7.4.1 AstraZeneca Details
7.4.2 AstraZeneca Major Business
7.4.3 AstraZeneca Nervous System Medications Product and Services
7.4.4 AstraZeneca Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 AstraZeneca Recent Developments/Updates
7.4.6 AstraZeneca Competitive Strengths & Weaknesses
7.5 Takeda
7.5.1 Takeda Details
7.5.2 Takeda Major Business
7.5.3 Takeda Nervous System Medications Product and Services
7.5.4 Takeda Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Takeda Recent Developments/Updates
7.5.6 Takeda Competitive Strengths & Weaknesses
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Details
7.6.2 Johnson & Johnson Major Business
7.6.3 Johnson & Johnson Nervous System Medications Product and Services
7.6.4 Johnson & Johnson Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Johnson & Johnson Recent Developments/Updates
7.6.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.7 EliLilly
7.7.1 EliLilly Details
7.7.2 EliLilly Major Business
7.7.3 EliLilly Nervous System Medications Product and Services
7.7.4 EliLilly Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 EliLilly Recent Developments/Updates
7.7.6 EliLilly Competitive Strengths & Weaknesses
7.8 Otsuka
7.8.1 Otsuka Details
7.8.2 Otsuka Major Business
7.8.3 Otsuka Nervous System Medications Product and Services
7.8.4 Otsuka Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Otsuka Recent Developments/Updates
7.8.6 Otsuka Competitive Strengths & Weaknesses
7.9 Merck
7.9.1 Merck Details
7.9.2 Merck Major Business
7.9.3 Merck Nervous System Medications Product and Services
7.9.4 Merck Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Merck Recent Developments/Updates
7.9.6 Merck Competitive Strengths & Weaknesses
7.10 Yangtze River Pharmaceutical
7.10.1 Yangtze River Pharmaceutical Details
7.10.2 Yangtze River Pharmaceutical Major Business
7.10.3 Yangtze River Pharmaceutical Nervous System Medications Product and Services
7.10.4 Yangtze River Pharmaceutical Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Yangtze River Pharmaceutical Recent Developments/Updates
7.10.6 Yangtze River Pharmaceutical Competitive Strengths & Weaknesses
7.11 Humanwell Healthcare
7.11.1 Humanwell Healthcare Details
7.11.2 Humanwell Healthcare Major Business
7.11.3 Humanwell Healthcare Nervous System Medications Product and Services
7.11.4 Humanwell Healthcare Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Humanwell Healthcare Recent Developments/Updates
7.11.6 Humanwell Healthcare Competitive Strengths & Weaknesses
7.12 CSPC-NBP Pharmaceutical
7.12.1 CSPC-NBP Pharmaceutical Details
7.12.2 CSPC-NBP Pharmaceutical Major Business
7.12.3 CSPC-NBP Pharmaceutical Nervous System Medications Product and Services
7.12.4 CSPC-NBP Pharmaceutical Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 CSPC-NBP Pharmaceutical Recent Developments/Updates
7.12.6 CSPC-NBP Pharmaceutical Competitive Strengths & Weaknesses
7.13 Nhwa Pharmaceutical
7.13.1 Nhwa Pharmaceutical Details
7.13.2 Nhwa Pharmaceutical Major Business
7.13.3 Nhwa Pharmaceutical Nervous System Medications Product and Services
7.13.4 Nhwa Pharmaceutical Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Nhwa Pharmaceutical Recent Developments/Updates
7.13.6 Nhwa Pharmaceutical Competitive Strengths & Weaknesses
7.14 Qilu Pharma
7.14.1 Qilu Pharma Details
7.14.2 Qilu Pharma Major Business
7.14.3 Qilu Pharma Nervous System Medications Product and Services
7.14.4 Qilu Pharma Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Qilu Pharma Recent Developments/Updates
7.14.6 Qilu Pharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Nervous System Medications Industry Chain
8.2 Nervous System Medications Upstream Analysis
8.2.1 Nervous System Medications Core Raw Materials
8.2.2 Main Manufacturers of Nervous System Medications Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Nervous System Medications Production Mode
8.6 Nervous System Medications Procurement Model
8.7 Nervous System Medications Industry Sales Model and Sales Channels
8.7.1 Nervous System Medications Sales Model
8.7.2 Nervous System Medications Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Nervous System Medications Introduction
1.2 World Nervous System Medications Supply & Forecast
1.2.1 World Nervous System Medications Production Value (2018 & 2022 & 2029)
1.2.2 World Nervous System Medications Production (2018-2029)
1.2.3 World Nervous System Medications Pricing Trends (2018-2029)
1.3 World Nervous System Medications Production by Region (Based on Production Site)
1.3.1 World Nervous System Medications Production Value by Region (2018-2029)
1.3.2 World Nervous System Medications Production by Region (2018-2029)
1.3.3 World Nervous System Medications Average Price by Region (2018-2029)
1.3.4 North America Nervous System Medications Production (2018-2029)
1.3.5 Europe Nervous System Medications Production (2018-2029)
1.3.6 China Nervous System Medications Production (2018-2029)
1.3.7 Japan Nervous System Medications Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nervous System Medications Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Nervous System Medications Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Nervous System Medications Demand (2018-2029)
2.2 World Nervous System Medications Consumption by Region
2.2.1 World Nervous System Medications Consumption by Region (2018-2023)
2.2.2 World Nervous System Medications Consumption Forecast by Region (2024-2029)
2.3 United States Nervous System Medications Consumption (2018-2029)
2.4 China Nervous System Medications Consumption (2018-2029)
2.5 Europe Nervous System Medications Consumption (2018-2029)
2.6 Japan Nervous System Medications Consumption (2018-2029)
2.7 South Korea Nervous System Medications Consumption (2018-2029)
2.8 ASEAN Nervous System Medications Consumption (2018-2029)
2.9 India Nervous System Medications Consumption (2018-2029)
3 WORLD NERVOUS SYSTEM MEDICATIONS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Nervous System Medications Production Value by Manufacturer (2018-2023)
3.2 World Nervous System Medications Production by Manufacturer (2018-2023)
3.3 World Nervous System Medications Average Price by Manufacturer (2018-2023)
3.4 Nervous System Medications Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Nervous System Medications Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Nervous System Medications in 2022
3.5.3 Global Concentration Ratios (CR8) for Nervous System Medications in 2022
3.6 Nervous System Medications Market: Overall Company Footprint Analysis
3.6.1 Nervous System Medications Market: Region Footprint
3.6.2 Nervous System Medications Market: Company Product Type Footprint
3.6.3 Nervous System Medications Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Nervous System Medications Production Value Comparison
4.1.1 United States VS China: Nervous System Medications Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Nervous System Medications Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Nervous System Medications Production Comparison
4.2.1 United States VS China: Nervous System Medications Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Nervous System Medications Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Nervous System Medications Consumption Comparison
4.3.1 United States VS China: Nervous System Medications Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Nervous System Medications Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Nervous System Medications Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Nervous System Medications Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Nervous System Medications Production Value (2018-2023)
4.4.3 United States Based Manufacturers Nervous System Medications Production (2018-2023)
4.5 China Based Nervous System Medications Manufacturers and Market Share
4.5.1 China Based Nervous System Medications Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Nervous System Medications Production Value (2018-2023)
4.5.3 China Based Manufacturers Nervous System Medications Production (2018-2023)
4.6 Rest of World Based Nervous System Medications Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Nervous System Medications Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Nervous System Medications Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Nervous System Medications Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Nervous System Medications Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Anesthetic
5.2.2 Painkiller
5.2.3 Psychostimulants
5.2.4 Antiepileptic Drugs
5.2.5 Anti-Parkinson Drugs
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Nervous System Medications Production by Type (2018-2029)
5.3.2 World Nervous System Medications Production Value by Type (2018-2029)
5.3.3 World Nervous System Medications Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Nervous System Medications Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacy
6.2.2 Retail Pharmacy
6.2.3 Online Pharmacy
6.3 Market Segment by Application
6.3.1 World Nervous System Medications Production by Application (2018-2029)
6.3.2 World Nervous System Medications Production Value by Application (2018-2029)
6.3.3 World Nervous System Medications Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Nervous System Medications Product and Services
7.1.4 Pfizer Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Teva
7.2.1 Teva Details
7.2.2 Teva Major Business
7.2.3 Teva Nervous System Medications Product and Services
7.2.4 Teva Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Teva Recent Developments/Updates
7.2.6 Teva Competitive Strengths & Weaknesses
7.3 Novartis
7.3.1 Novartis Details
7.3.2 Novartis Major Business
7.3.3 Novartis Nervous System Medications Product and Services
7.3.4 Novartis Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Novartis Recent Developments/Updates
7.3.6 Novartis Competitive Strengths & Weaknesses
7.4 AstraZeneca
7.4.1 AstraZeneca Details
7.4.2 AstraZeneca Major Business
7.4.3 AstraZeneca Nervous System Medications Product and Services
7.4.4 AstraZeneca Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 AstraZeneca Recent Developments/Updates
7.4.6 AstraZeneca Competitive Strengths & Weaknesses
7.5 Takeda
7.5.1 Takeda Details
7.5.2 Takeda Major Business
7.5.3 Takeda Nervous System Medications Product and Services
7.5.4 Takeda Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Takeda Recent Developments/Updates
7.5.6 Takeda Competitive Strengths & Weaknesses
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Details
7.6.2 Johnson & Johnson Major Business
7.6.3 Johnson & Johnson Nervous System Medications Product and Services
7.6.4 Johnson & Johnson Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Johnson & Johnson Recent Developments/Updates
7.6.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.7 EliLilly
7.7.1 EliLilly Details
7.7.2 EliLilly Major Business
7.7.3 EliLilly Nervous System Medications Product and Services
7.7.4 EliLilly Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 EliLilly Recent Developments/Updates
7.7.6 EliLilly Competitive Strengths & Weaknesses
7.8 Otsuka
7.8.1 Otsuka Details
7.8.2 Otsuka Major Business
7.8.3 Otsuka Nervous System Medications Product and Services
7.8.4 Otsuka Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Otsuka Recent Developments/Updates
7.8.6 Otsuka Competitive Strengths & Weaknesses
7.9 Merck
7.9.1 Merck Details
7.9.2 Merck Major Business
7.9.3 Merck Nervous System Medications Product and Services
7.9.4 Merck Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Merck Recent Developments/Updates
7.9.6 Merck Competitive Strengths & Weaknesses
7.10 Yangtze River Pharmaceutical
7.10.1 Yangtze River Pharmaceutical Details
7.10.2 Yangtze River Pharmaceutical Major Business
7.10.3 Yangtze River Pharmaceutical Nervous System Medications Product and Services
7.10.4 Yangtze River Pharmaceutical Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Yangtze River Pharmaceutical Recent Developments/Updates
7.10.6 Yangtze River Pharmaceutical Competitive Strengths & Weaknesses
7.11 Humanwell Healthcare
7.11.1 Humanwell Healthcare Details
7.11.2 Humanwell Healthcare Major Business
7.11.3 Humanwell Healthcare Nervous System Medications Product and Services
7.11.4 Humanwell Healthcare Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Humanwell Healthcare Recent Developments/Updates
7.11.6 Humanwell Healthcare Competitive Strengths & Weaknesses
7.12 CSPC-NBP Pharmaceutical
7.12.1 CSPC-NBP Pharmaceutical Details
7.12.2 CSPC-NBP Pharmaceutical Major Business
7.12.3 CSPC-NBP Pharmaceutical Nervous System Medications Product and Services
7.12.4 CSPC-NBP Pharmaceutical Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 CSPC-NBP Pharmaceutical Recent Developments/Updates
7.12.6 CSPC-NBP Pharmaceutical Competitive Strengths & Weaknesses
7.13 Nhwa Pharmaceutical
7.13.1 Nhwa Pharmaceutical Details
7.13.2 Nhwa Pharmaceutical Major Business
7.13.3 Nhwa Pharmaceutical Nervous System Medications Product and Services
7.13.4 Nhwa Pharmaceutical Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Nhwa Pharmaceutical Recent Developments/Updates
7.13.6 Nhwa Pharmaceutical Competitive Strengths & Weaknesses
7.14 Qilu Pharma
7.14.1 Qilu Pharma Details
7.14.2 Qilu Pharma Major Business
7.14.3 Qilu Pharma Nervous System Medications Product and Services
7.14.4 Qilu Pharma Nervous System Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Qilu Pharma Recent Developments/Updates
7.14.6 Qilu Pharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Nervous System Medications Industry Chain
8.2 Nervous System Medications Upstream Analysis
8.2.1 Nervous System Medications Core Raw Materials
8.2.2 Main Manufacturers of Nervous System Medications Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Nervous System Medications Production Mode
8.6 Nervous System Medications Procurement Model
8.7 Nervous System Medications Industry Sales Model and Sales Channels
8.7.1 Nervous System Medications Sales Model
8.7.2 Nervous System Medications Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Nervous System Medications Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Nervous System Medications Production Value by Region (2018-2023) & (USD Million)
Table 3. World Nervous System Medications Production Value by Region (2024-2029) & (USD Million)
Table 4. World Nervous System Medications Production Value Market Share by Region (2018-2023)
Table 5. World Nervous System Medications Production Value Market Share by Region (2024-2029)
Table 6. World Nervous System Medications Production by Region (2018-2023) & (K Units)
Table 7. World Nervous System Medications Production by Region (2024-2029) & (K Units)
Table 8. World Nervous System Medications Production Market Share by Region (2018-2023)
Table 9. World Nervous System Medications Production Market Share by Region (2024-2029)
Table 10. World Nervous System Medications Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Nervous System Medications Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Nervous System Medications Major Market Trends
Table 13. World Nervous System Medications Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Nervous System Medications Consumption by Region (2018-2023) & (K Units)
Table 15. World Nervous System Medications Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Nervous System Medications Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Nervous System Medications Producers in 2022
Table 18. World Nervous System Medications Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Nervous System Medications Producers in 2022
Table 20. World Nervous System Medications Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Nervous System Medications Company Evaluation Quadrant
Table 22. World Nervous System Medications Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Nervous System Medications Production Site of Key Manufacturer
Table 24. Nervous System Medications Market: Company Product Type Footprint
Table 25. Nervous System Medications Market: Company Product Application Footprint
Table 26. Nervous System Medications Competitive Factors
Table 27. Nervous System Medications New Entrant and Capacity Expansion Plans
Table 28. Nervous System Medications Mergers & Acquisitions Activity
Table 29. United States VS China Nervous System Medications Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Nervous System Medications Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Nervous System Medications Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Nervous System Medications Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Nervous System Medications Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Nervous System Medications Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Nervous System Medications Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Nervous System Medications Production Market Share (2018-2023)
Table 37. China Based Nervous System Medications Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Nervous System Medications Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Nervous System Medications Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Nervous System Medications Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Nervous System Medications Production Market Share (2018-2023)
Table 42. Rest of World Based Nervous System Medications Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Nervous System Medications Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Nervous System Medications Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Nervous System Medications Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Nervous System Medications Production Market Share (2018-2023)
Table 47. World Nervous System Medications Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Nervous System Medications Production by Type (2018-2023) & (K Units)
Table 49. World Nervous System Medications Production by Type (2024-2029) & (K Units)
Table 50. World Nervous System Medications Production Value by Type (2018-2023) & (USD Million)
Table 51. World Nervous System Medications Production Value by Type (2024-2029) & (USD Million)
Table 52. World Nervous System Medications Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Nervous System Medications Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Nervous System Medications Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Nervous System Medications Production by Application (2018-2023) & (K Units)
Table 56. World Nervous System Medications Production by Application (2024-2029) & (K Units)
Table 57. World Nervous System Medications Production Value by Application (2018-2023) & (USD Million)
Table 58. World Nervous System Medications Production Value by Application (2024-2029) & (USD Million)
Table 59. World Nervous System Medications Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Nervous System Medications Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Nervous System Medications Product and Services
Table 64. Pfizer Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Teva Basic Information, Manufacturing Base and Competitors
Table 68. Teva Major Business
Table 69. Teva Nervous System Medications Product and Services
Table 70. Teva Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Teva Recent Developments/Updates
Table 72. Teva Competitive Strengths & Weaknesses
Table 73. Novartis Basic Information, Manufacturing Base and Competitors
Table 74. Novartis Major Business
Table 75. Novartis Nervous System Medications Product and Services
Table 76. Novartis Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Novartis Recent Developments/Updates
Table 78. Novartis Competitive Strengths & Weaknesses
Table 79. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 80. AstraZeneca Major Business
Table 81. AstraZeneca Nervous System Medications Product and Services
Table 82. AstraZeneca Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. AstraZeneca Recent Developments/Updates
Table 84. AstraZeneca Competitive Strengths & Weaknesses
Table 85. Takeda Basic Information, Manufacturing Base and Competitors
Table 86. Takeda Major Business
Table 87. Takeda Nervous System Medications Product and Services
Table 88. Takeda Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Takeda Recent Developments/Updates
Table 90. Takeda Competitive Strengths & Weaknesses
Table 91. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 92. Johnson & Johnson Major Business
Table 93. Johnson & Johnson Nervous System Medications Product and Services
Table 94. Johnson & Johnson Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Johnson & Johnson Recent Developments/Updates
Table 96. Johnson & Johnson Competitive Strengths & Weaknesses
Table 97. EliLilly Basic Information, Manufacturing Base and Competitors
Table 98. EliLilly Major Business
Table 99. EliLilly Nervous System Medications Product and Services
Table 100. EliLilly Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. EliLilly Recent Developments/Updates
Table 102. EliLilly Competitive Strengths & Weaknesses
Table 103. Otsuka Basic Information, Manufacturing Base and Competitors
Table 104. Otsuka Major Business
Table 105. Otsuka Nervous System Medications Product and Services
Table 106. Otsuka Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Otsuka Recent Developments/Updates
Table 108. Otsuka Competitive Strengths & Weaknesses
Table 109. Merck Basic Information, Manufacturing Base and Competitors
Table 110. Merck Major Business
Table 111. Merck Nervous System Medications Product and Services
Table 112. Merck Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Merck Recent Developments/Updates
Table 114. Merck Competitive Strengths & Weaknesses
Table 115. Yangtze River Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Yangtze River Pharmaceutical Major Business
Table 117. Yangtze River Pharmaceutical Nervous System Medications Product and Services
Table 118. Yangtze River Pharmaceutical Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Yangtze River Pharmaceutical Recent Developments/Updates
Table 120. Yangtze River Pharmaceutical Competitive Strengths & Weaknesses
Table 121. Humanwell Healthcare Basic Information, Manufacturing Base and Competitors
Table 122. Humanwell Healthcare Major Business
Table 123. Humanwell Healthcare Nervous System Medications Product and Services
Table 124. Humanwell Healthcare Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Humanwell Healthcare Recent Developments/Updates
Table 126. Humanwell Healthcare Competitive Strengths & Weaknesses
Table 127. CSPC-NBP Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 128. CSPC-NBP Pharmaceutical Major Business
Table 129. CSPC-NBP Pharmaceutical Nervous System Medications Product and Services
Table 130. CSPC-NBP Pharmaceutical Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. CSPC-NBP Pharmaceutical Recent Developments/Updates
Table 132. CSPC-NBP Pharmaceutical Competitive Strengths & Weaknesses
Table 133. Nhwa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 134. Nhwa Pharmaceutical Major Business
Table 135. Nhwa Pharmaceutical Nervous System Medications Product and Services
Table 136. Nhwa Pharmaceutical Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Nhwa Pharmaceutical Recent Developments/Updates
Table 138. Qilu Pharma Basic Information, Manufacturing Base and Competitors
Table 139. Qilu Pharma Major Business
Table 140. Qilu Pharma Nervous System Medications Product and Services
Table 141. Qilu Pharma Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Global Key Players of Nervous System Medications Upstream (Raw Materials)
Table 143. Nervous System Medications Typical Customers
Table 144. Nervous System Medications Typical Distributors
Table 1. World Nervous System Medications Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Nervous System Medications Production Value by Region (2018-2023) & (USD Million)
Table 3. World Nervous System Medications Production Value by Region (2024-2029) & (USD Million)
Table 4. World Nervous System Medications Production Value Market Share by Region (2018-2023)
Table 5. World Nervous System Medications Production Value Market Share by Region (2024-2029)
Table 6. World Nervous System Medications Production by Region (2018-2023) & (K Units)
Table 7. World Nervous System Medications Production by Region (2024-2029) & (K Units)
Table 8. World Nervous System Medications Production Market Share by Region (2018-2023)
Table 9. World Nervous System Medications Production Market Share by Region (2024-2029)
Table 10. World Nervous System Medications Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Nervous System Medications Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Nervous System Medications Major Market Trends
Table 13. World Nervous System Medications Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Nervous System Medications Consumption by Region (2018-2023) & (K Units)
Table 15. World Nervous System Medications Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Nervous System Medications Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Nervous System Medications Producers in 2022
Table 18. World Nervous System Medications Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Nervous System Medications Producers in 2022
Table 20. World Nervous System Medications Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Nervous System Medications Company Evaluation Quadrant
Table 22. World Nervous System Medications Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Nervous System Medications Production Site of Key Manufacturer
Table 24. Nervous System Medications Market: Company Product Type Footprint
Table 25. Nervous System Medications Market: Company Product Application Footprint
Table 26. Nervous System Medications Competitive Factors
Table 27. Nervous System Medications New Entrant and Capacity Expansion Plans
Table 28. Nervous System Medications Mergers & Acquisitions Activity
Table 29. United States VS China Nervous System Medications Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Nervous System Medications Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Nervous System Medications Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Nervous System Medications Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Nervous System Medications Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Nervous System Medications Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Nervous System Medications Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Nervous System Medications Production Market Share (2018-2023)
Table 37. China Based Nervous System Medications Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Nervous System Medications Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Nervous System Medications Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Nervous System Medications Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Nervous System Medications Production Market Share (2018-2023)
Table 42. Rest of World Based Nervous System Medications Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Nervous System Medications Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Nervous System Medications Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Nervous System Medications Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Nervous System Medications Production Market Share (2018-2023)
Table 47. World Nervous System Medications Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Nervous System Medications Production by Type (2018-2023) & (K Units)
Table 49. World Nervous System Medications Production by Type (2024-2029) & (K Units)
Table 50. World Nervous System Medications Production Value by Type (2018-2023) & (USD Million)
Table 51. World Nervous System Medications Production Value by Type (2024-2029) & (USD Million)
Table 52. World Nervous System Medications Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Nervous System Medications Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Nervous System Medications Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Nervous System Medications Production by Application (2018-2023) & (K Units)
Table 56. World Nervous System Medications Production by Application (2024-2029) & (K Units)
Table 57. World Nervous System Medications Production Value by Application (2018-2023) & (USD Million)
Table 58. World Nervous System Medications Production Value by Application (2024-2029) & (USD Million)
Table 59. World Nervous System Medications Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Nervous System Medications Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Nervous System Medications Product and Services
Table 64. Pfizer Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Teva Basic Information, Manufacturing Base and Competitors
Table 68. Teva Major Business
Table 69. Teva Nervous System Medications Product and Services
Table 70. Teva Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Teva Recent Developments/Updates
Table 72. Teva Competitive Strengths & Weaknesses
Table 73. Novartis Basic Information, Manufacturing Base and Competitors
Table 74. Novartis Major Business
Table 75. Novartis Nervous System Medications Product and Services
Table 76. Novartis Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Novartis Recent Developments/Updates
Table 78. Novartis Competitive Strengths & Weaknesses
Table 79. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 80. AstraZeneca Major Business
Table 81. AstraZeneca Nervous System Medications Product and Services
Table 82. AstraZeneca Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. AstraZeneca Recent Developments/Updates
Table 84. AstraZeneca Competitive Strengths & Weaknesses
Table 85. Takeda Basic Information, Manufacturing Base and Competitors
Table 86. Takeda Major Business
Table 87. Takeda Nervous System Medications Product and Services
Table 88. Takeda Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Takeda Recent Developments/Updates
Table 90. Takeda Competitive Strengths & Weaknesses
Table 91. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 92. Johnson & Johnson Major Business
Table 93. Johnson & Johnson Nervous System Medications Product and Services
Table 94. Johnson & Johnson Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Johnson & Johnson Recent Developments/Updates
Table 96. Johnson & Johnson Competitive Strengths & Weaknesses
Table 97. EliLilly Basic Information, Manufacturing Base and Competitors
Table 98. EliLilly Major Business
Table 99. EliLilly Nervous System Medications Product and Services
Table 100. EliLilly Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. EliLilly Recent Developments/Updates
Table 102. EliLilly Competitive Strengths & Weaknesses
Table 103. Otsuka Basic Information, Manufacturing Base and Competitors
Table 104. Otsuka Major Business
Table 105. Otsuka Nervous System Medications Product and Services
Table 106. Otsuka Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Otsuka Recent Developments/Updates
Table 108. Otsuka Competitive Strengths & Weaknesses
Table 109. Merck Basic Information, Manufacturing Base and Competitors
Table 110. Merck Major Business
Table 111. Merck Nervous System Medications Product and Services
Table 112. Merck Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Merck Recent Developments/Updates
Table 114. Merck Competitive Strengths & Weaknesses
Table 115. Yangtze River Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Yangtze River Pharmaceutical Major Business
Table 117. Yangtze River Pharmaceutical Nervous System Medications Product and Services
Table 118. Yangtze River Pharmaceutical Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Yangtze River Pharmaceutical Recent Developments/Updates
Table 120. Yangtze River Pharmaceutical Competitive Strengths & Weaknesses
Table 121. Humanwell Healthcare Basic Information, Manufacturing Base and Competitors
Table 122. Humanwell Healthcare Major Business
Table 123. Humanwell Healthcare Nervous System Medications Product and Services
Table 124. Humanwell Healthcare Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Humanwell Healthcare Recent Developments/Updates
Table 126. Humanwell Healthcare Competitive Strengths & Weaknesses
Table 127. CSPC-NBP Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 128. CSPC-NBP Pharmaceutical Major Business
Table 129. CSPC-NBP Pharmaceutical Nervous System Medications Product and Services
Table 130. CSPC-NBP Pharmaceutical Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. CSPC-NBP Pharmaceutical Recent Developments/Updates
Table 132. CSPC-NBP Pharmaceutical Competitive Strengths & Weaknesses
Table 133. Nhwa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 134. Nhwa Pharmaceutical Major Business
Table 135. Nhwa Pharmaceutical Nervous System Medications Product and Services
Table 136. Nhwa Pharmaceutical Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Nhwa Pharmaceutical Recent Developments/Updates
Table 138. Qilu Pharma Basic Information, Manufacturing Base and Competitors
Table 139. Qilu Pharma Major Business
Table 140. Qilu Pharma Nervous System Medications Product and Services
Table 141. Qilu Pharma Nervous System Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Global Key Players of Nervous System Medications Upstream (Raw Materials)
Table 143. Nervous System Medications Typical Customers
Table 144. Nervous System Medications Typical Distributors
LIST OF FIGURES
Figure 1. Nervous System Medications Picture
Figure 2. World Nervous System Medications Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Nervous System Medications Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Nervous System Medications Production (2018-2029) & (K Units)
Figure 5. World Nervous System Medications Average Price (2018-2029) & (US$/Unit)
Figure 6. World Nervous System Medications Production Value Market Share by Region (2018-2029)
Figure 7. World Nervous System Medications Production Market Share by Region (2018-2029)
Figure 8. North America Nervous System Medications Production (2018-2029) & (K Units)
Figure 9. Europe Nervous System Medications Production (2018-2029) & (K Units)
Figure 10. China Nervous System Medications Production (2018-2029) & (K Units)
Figure 11. Japan Nervous System Medications Production (2018-2029) & (K Units)
Figure 12. Nervous System Medications Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Nervous System Medications Consumption (2018-2029) & (K Units)
Figure 15. World Nervous System Medications Consumption Market Share by Region (2018-2029)
Figure 16. United States Nervous System Medications Consumption (2018-2029) & (K Units)
Figure 17. China Nervous System Medications Consumption (2018-2029) & (K Units)
Figure 18. Europe Nervous System Medications Consumption (2018-2029) & (K Units)
Figure 19. Japan Nervous System Medications Consumption (2018-2029) & (K Units)
Figure 20. South Korea Nervous System Medications Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Nervous System Medications Consumption (2018-2029) & (K Units)
Figure 22. India Nervous System Medications Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Nervous System Medications by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Nervous System Medications Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Nervous System Medications Markets in 2022
Figure 26. United States VS China: Nervous System Medications Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Nervous System Medications Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Nervous System Medications Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Nervous System Medications Production Market Share 2022
Figure 30. China Based Manufacturers Nervous System Medications Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Nervous System Medications Production Market Share 2022
Figure 32. World Nervous System Medications Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Nervous System Medications Production Value Market Share by Type in 2022
Figure 34. Anesthetic
Figure 35. Painkiller
Figure 36. Psychostimulants
Figure 37. Antiepileptic Drugs
Figure 38. Anti-Parkinson Drugs
Figure 39. Others
Figure 40. World Nervous System Medications Production Market Share by Type (2018-2029)
Figure 41. World Nervous System Medications Production Value Market Share by Type (2018-2029)
Figure 42. World Nervous System Medications Average Price by Type (2018-2029) & (US$/Unit)
Figure 43. World Nervous System Medications Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 44. World Nervous System Medications Production Value Market Share by Application in 2022
Figure 45. Hospital Pharmacy
Figure 46. Retail Pharmacy
Figure 47. Online Pharmacy
Figure 48. World Nervous System Medications Production Market Share by Application (2018-2029)
Figure 49. World Nervous System Medications Production Value Market Share by Application (2018-2029)
Figure 50. World Nervous System Medications Average Price by Application (2018-2029) & (US$/Unit)
Figure 51. Nervous System Medications Industry Chain
Figure 52. Nervous System Medications Procurement Model
Figure 53. Nervous System Medications Sales Model
Figure 54. Nervous System Medications Sales Channels, Direct Sales, and Distribution
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. Nervous System Medications Picture
Figure 2. World Nervous System Medications Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Nervous System Medications Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Nervous System Medications Production (2018-2029) & (K Units)
Figure 5. World Nervous System Medications Average Price (2018-2029) & (US$/Unit)
Figure 6. World Nervous System Medications Production Value Market Share by Region (2018-2029)
Figure 7. World Nervous System Medications Production Market Share by Region (2018-2029)
Figure 8. North America Nervous System Medications Production (2018-2029) & (K Units)
Figure 9. Europe Nervous System Medications Production (2018-2029) & (K Units)
Figure 10. China Nervous System Medications Production (2018-2029) & (K Units)
Figure 11. Japan Nervous System Medications Production (2018-2029) & (K Units)
Figure 12. Nervous System Medications Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Nervous System Medications Consumption (2018-2029) & (K Units)
Figure 15. World Nervous System Medications Consumption Market Share by Region (2018-2029)
Figure 16. United States Nervous System Medications Consumption (2018-2029) & (K Units)
Figure 17. China Nervous System Medications Consumption (2018-2029) & (K Units)
Figure 18. Europe Nervous System Medications Consumption (2018-2029) & (K Units)
Figure 19. Japan Nervous System Medications Consumption (2018-2029) & (K Units)
Figure 20. South Korea Nervous System Medications Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Nervous System Medications Consumption (2018-2029) & (K Units)
Figure 22. India Nervous System Medications Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Nervous System Medications by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Nervous System Medications Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Nervous System Medications Markets in 2022
Figure 26. United States VS China: Nervous System Medications Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Nervous System Medications Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Nervous System Medications Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Nervous System Medications Production Market Share 2022
Figure 30. China Based Manufacturers Nervous System Medications Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Nervous System Medications Production Market Share 2022
Figure 32. World Nervous System Medications Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Nervous System Medications Production Value Market Share by Type in 2022
Figure 34. Anesthetic
Figure 35. Painkiller
Figure 36. Psychostimulants
Figure 37. Antiepileptic Drugs
Figure 38. Anti-Parkinson Drugs
Figure 39. Others
Figure 40. World Nervous System Medications Production Market Share by Type (2018-2029)
Figure 41. World Nervous System Medications Production Value Market Share by Type (2018-2029)
Figure 42. World Nervous System Medications Average Price by Type (2018-2029) & (US$/Unit)
Figure 43. World Nervous System Medications Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 44. World Nervous System Medications Production Value Market Share by Application in 2022
Figure 45. Hospital Pharmacy
Figure 46. Retail Pharmacy
Figure 47. Online Pharmacy
Figure 48. World Nervous System Medications Production Market Share by Application (2018-2029)
Figure 49. World Nervous System Medications Production Value Market Share by Application (2018-2029)
Figure 50. World Nervous System Medications Average Price by Application (2018-2029) & (US$/Unit)
Figure 51. Nervous System Medications Industry Chain
Figure 52. Nervous System Medications Procurement Model
Figure 53. Nervous System Medications Sales Model
Figure 54. Nervous System Medications Sales Channels, Direct Sales, and Distribution
Figure 55. Methodology
Figure 56. Research Process and Data Source
